New products are received with great apprehension as it cannot be aptly said if the product will survive the market competition or not. When a new product is introduced into the market, there is no guarantee that the product is going to be accepted or otherwise. Users hesitate to buy a new product as they are unsure if their investment will go as a waste and thus it certainly takes time for consumers to understand the use and need of the new product before they accept it in their daily lives. Smoking is a habit which becomes part and parcel of smoker’s lives and it is hard to quit smoking once you have got into the habit of the same. Most of the smokers would like to get rid of it but find themselves trapped in it. To help such quitters and smokers has thus been created the electronic cigarettes which is a smart choice over ordinary smoking.
Electronic cigarettes are available all throughout the world and are a product of legal use in the United States but there are also subjected to state legislation. The Food and Drug administration lost its court battle against electronic cigarettes in 2010 as the FDA wanted this device to be classified as a drug delivery device. However, after several proceedings the court’s verdict was against the FDA and this cleared the way for the marketing process of electronic cigarettes. This product also hit the European market in 2006 under the name of Ruyan and after its introduction in this market; the product was named as electronic cigarette.
It is the health aspect of electronic cigarettes which needs to be confirmed as there is still uncertainty looming over the positive features of electronic cigarettes. The FDA is quite concerned over the use of the electronic cigarettes as in the studies conducted by it over the 19 varieties of this device, diethylene glycol was found in the cartridges of one of the brands and carcinogens known as tobacco-specific nitrosamines or TSNAs are also found in one or two of the cartridges which actually raised many serious concerns over the use of electronic cigarettes and this is the main reason why FDA filed a case against this device. But, the Electronic Cigarette Association counteracted on the FDA testing and clearly stated that FDA’s research lacked proper proof. Most of the research work and testing revealed mixed results and the American Association of Public Health Physicians offered its full support to electronic cigarettes and they strongly recommended that this device should not be classified under drug device delivery but instead should be classified as a tobacco product. AAPHP clearly propagates that this product produces very less second hand smoke than compared to the usual cigarettes. WHO is also of the view that electronic cigarettes should be marketed as a smoking cessation device and no brand of this product should contain any suggestion that WHO has approved the device.
Every user of electronic cigarette needs to necessarily take into consideration the pros and cons of using this device before they start using it on a daily basis.
Tue, May 17, 2011
Electronic Cigarette